Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep297 | Calcium & Vitamin D metabolism | ECE2017

Tc-99m sestamibi uptake by brown tumours in a patient with primary hyperparathyroidism

Dias Daniela , Macedo Daniel , Santos Rita , Leite Valeriano

Tc-99m sestamibi (MIBI) imaging is able to localize parathyroid adenomas/carcinomas in patients with primary hyperparathyroidism. Brown tumours are one of the skeletal manifestations of long standing hyperparathyroidism and its incidence has been reported to be 3%. Radiological features of these tumors may mimic bone metastasis. There are only a few reports showing brown tumours uptake in the whole-body Tc-sestamibi scan.We report a 72-year-old female wi...

ea0049ep512 | Diabetes complications | ECE2017

Metabolic risk factors in adolescent girls with type 1 diabetes

Pinheiro Marta Isabel , Oliveira Juliana , Silva Rita Santos , Correia Cintia Castro , Fontoura Manuel

Background: Adolescent girls with type 1 diabetes (T1DM) have a higher incidence of metabolic risk factors like hypertension, dyslipidemia, non-alcoholic hepatic steatosis (NASH), abdominal adiposity and polycystic ovarian syndrome (PCOS) when compared with their non-diabetic peers. Moreover, metabolic risk factors seem to appear even in T1DM girls without overweight or obesity. We aimed to determine the prevalence of several metabolic risk factors in adolescent T1DM females, ...

ea0020p157 | Thyroid | ECE2009

Bronchiectasis as a false-positive on Iodine-131 scintigraphy in thyroid papillary carcinoma- three case reports

Martins Anabela , Rosario Francisco , Garrao Antonio , Quaresma Pedro , Ferreira Teresa , Santos Rita , Bugalho Maria , Leite Valeriano

Introduction: After treatment with Iodine-131(I-131) in differentiated thyroid cancer, a diagnostic scintigraphy is performed. We selected three cases in which bronchiectasis appear as a false-positive on the scintigraphy after treatment with I-131.Case reports: Three women, respectively 62, 64 and 65 years old, being followed in the Endocrinology Department of our Institute, with the diagnosis of papillary carcinoma of the thyroid, were submitted to I-1...

ea0020p158 | Thyroid | ECE2009

Combined doxorubicin and hyperfracionated radiation therapy of anaplastic thyroid carcinoma: case report

Martins Anabela , Rosario Francisco , Trindade Candida , Santos Rita , Bugalho Maria , Leite Valeriano

Introduction: Anaplastic thyroid carcinoma, either by its low frequency, or by its poor prognosis, is still as a therapeutic challenge. One of the options available is the combined chemoradiation therapy, the basis of the following case.Case report: Male patient, 76 years old, with a history of neck swelling for 4 months. The cervical ultrasound showed a nodule in the right lobe of the thyroid with 7 by 5 cm and the cytology revealed follicular tumor. Su...

ea0049gp227 | Thyroid Cancer | ECE2017

Fine needle aspiration biopsy in pediatric patients with thyroid nodules

Costa Maria Manuel , Silva Rita Santos , Castro-Correia Cintia , Sucesso Maria Bom , Coelho Tiago Henriques , Barroca Helena , Fontoura Manuel

Introduction: Although thyroid nodules (TN) are less common in children than in adults, the risk of malignancy is much higher in pediatric age and therefore representing greater concern in this age group.Objective: Evaluate a cohort of pediatric patients with TN and search differences between subjects with malignant and benign TN regarding sex, age, compressive symptoms, cervical ultrasound characteristics, family history of differentiated thyroid cancer...

ea0084ps3-14-132 | Thyroid Cancer CLINICAL 2 | ETA2022

Efficacy and safety of lenvatinib in a cohort of well-differentiated advanced thyroid carcinomas

Damasio Ines , Maciel Joana , Figueiredo Ana , Simoes Helder , Nunes da Silva Tiago , Simoes-Pereira Joana , Horta Mariana , Santos Rita , Donato Sara , Leite Valeriano

Introduction: Treatment of differentiated thyroid carcinoma (DTC) remains a challenge in the setting of locally advanced or metastatic disease refractory to radiodine (RAI) therapy. SELECT trial demonstrated that Lenvatinib improved progression free survival (PFS) comparing to placebo.Objective: Our aim is to report the efficacy and safety of lenvatinib in our population with aggressive DTC.Methods: We retrospectively reviewed the ...

ea0073aep69 | Adrenal and Cardiovascular Endocrinology | ECE2021

Quality of life in children diagnosed with non-classic congenital adrenal hyperplasia

Maria João Ferreira , Moita Rita , Borges-Canha Marta , Silva Rita Santos , Ferreira Sofia , Costa Carla , Carvalho Davide , Cíntia Castro-Correia

IntroductionNon-classical congenital adrenal hyperplasia (NC-CAH) is a chronic disease characterized by excessive androgen production. Affected children may have their quality of life negatively affected by the awareness of a medical condition, symptoms of hyperandrogenism and the burden of daily medication administration. Pediatric Quality of Life Inventory 4.0 (PedsQL) is a validated tool to assess health-related QoL (HRQoL).Meth...

ea0070aep953 | Thyroid | ECE2020

Diagnostic patterns of relapsed differentiated thyroid cancer (DTC) and the efficacy of rescue therapies (ERUDIT Study)

Sambo Marcel , Navarro Elena , Aller Javier , Guadalix Sonsoles , Zafón Carlos , González Cristina , Santamaría Javier , González Marcelino , Puig Manel , Galofré Juan C. , Argüelles Iñaki , Vallejo Juan A. , Pubul Virginia , Santos Rita , Llanos Marta , Crespo Guillermo , Segura Ángel , Navarro Miguel , Gajate Pablo , Valdivia Javier , López Carlos , Castelo Beatriz , Villanueva María J. , Araujo Fábia , Orcajo Lorenzo , Rodríguez-Villanueva Julio

Introduction: Advanced differentiated thyroid carcinoma (aDTC) – herein defined as locally unresectable or metastatic disease – is one of the most common late-stage endocrine neoplasias. However, available data about its natural history is limited. ERUDIT is a multicenter, observational, retrospective study of patients diagnosed with aDTC in Spain and Portugal. The study describes its natural history from the initial diagnosis until the advanced stages of disease, ...

ea0073aep871 | Late Breaking | ECE2021

Relapsed Differentiated Thyroid Cancer, clinical presentation, treatment, and prognostic factors (ERUDIT Study)

Sambo Marcel , Elena Navarro González , Aller Pardo Javier , Guadalix Iglesias Sonsoles , Carles Zafón Llopis , Cintia González Blanco , Javier Santamaría Sandi , Marcelino Gómez Balaguer , Puig Domingo Manel , Juan C. Galofré Ferrater , Iñaki Argüelles Jiménez , Santos Rita , Marta Llanos Muñoz , Juan Antonio Vallejo Casas , Virginia Pubul Núñez , Crespo Herrero Guillermo , Ángel Segura Huerta , Miguel Navarro Martín , Gajate Borau Pablo , Valdivia Bautista Javier , Beatriz Castelo Fernández , Carlos López López , María J. Villanueva Silva , Orcajo Lorenzo , Julio Rodríguez-Villanueva García

Advanced differentiated thyroid carcinoma (aDTC), herein defined as locally unresectable and/or metastatic, is one of the most common late-stage endocrine neoplasias. However, available data about its natural history are limited. ERUDIT is a multicenter, observational, retrospective study of patients diagnosed with aDTC in Spain and Portugal. The study describes its natural history from the initial diagnosis until the advanced stages, focusing on specific characteristics of th...